Integral Health Asset Management, LLC
New York, NY · CIK 1773206 · 13F filing filed 2025-08-14
SEC-registered investment adviser since 2020 · limited liability company
- Assets managed$1.9bn
- Staff12 · 8 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $60.2m gross assets
- Websiteintegralhlth.com
- Form ADV · 2026-03-26SEC adviser record
- Legal entityINTEGRAL HEALTH ASSET MANAGEMENT, LLC (US)
- Kindhedge funds
- Others nearbyNew York, NY
As an employer
- Offices in1 country
- Private fundshedge 1
$1.1bn
reported value
+18.6% vs Q1 2025
70positions
45.5%in top 10
18 new
24 added
16 reduced
24 sold out
vs Q1 2025
Options: 2 call positions ($21.8m notional), 0 put positions (— notional) – listed below, not included above.
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| INSMED INC INSM | $161.0m15.04% | Added +50.0k |
| BOSTON SCIENTIFIC CORP BSX | $59.1m5.52% | Reduced -100.0k |
| TENET HEALTHCARE CORP THC | $48.4m4.52% | Unchanged |
| ENCOMPASS HEALTH CORP EHC | $39.2m3.67% | Added +50.0k |
| MINERALYS THERAPEUTICS INC MLYS | $36.5m3.41% | Added +400.0k |
| CYTOKINETICS INC CYTK | $33.0m3.09% | Reduced -100.0k |
| BRIGHTSPRING HEALTH SVCS INC BTSG | $29.5m2.75% | Added +475.0k |
| VERA THERAPEUTICS INC VERA | $27.1m2.53% | Unchanged |
| QUEST DIAGNOSTICS INC DGX | $26.9m2.52% | New |
| REGENERON PHARMACEUTICALS REGN | $26.2m2.45% | New |
| NOVARTIS AG NVS | $24.2m2.26% | Reduced -50.0k |
| CARDINAL HEALTH INC CAH | $23.5m2.20% | New |
| ELEVANCE HEALTH INC ELV | $23.3m2.18% | Reduced -5.0k |
| RADNET INC RDNT | $22.8m2.13% | Added +150.0k |
| FRESENIUS MEDICAL CARE AG FMS | $21.4m2.00% | Added +70.0k |
| ELI LILLY & CO LLY | $19.5m1.82% | New |
| NEUROCRINE BIOSCIENCES INC NBIX | $18.9m1.76% | Unchanged |
| UNIQURE NV QURE | $18.8m1.76% | Added +100.0k |
| ALNYLAM PHARMACEUTICALS INC ALNY | $17.9m1.68% | Added +5.0k |
| DEXCOM INC DXCM | $17.5m1.63% | Added +100.0k |
| CHARLES RIV LABS INTL INC CRL | $17.4m1.63% | New |
| MEDTRONIC PLC MDT | $17.4m1.63% | Reduced -100.0k |
| CVS HEALTH CORP CVS | $17.2m1.61% | Added +50.0k |
| PFIZER INC PFE | $17.0m1.59% | Added +400.0k |
| EDWARDS LIFESCIENCES CORP EW | $15.6m1.46% | Added +75.0k |
| GE HEALTHCARE TECHNOLOGIES I GEHC | $14.8m1.38% | Added +50.0k |
| ASTRAZENECA PLC SPONSORED ADR | $14.0m1.31% | New |
| EDGEWISE THERAPEUTICS INC EWTX | $13.1m1.22% | Added +325.0k |
| ORIC PHARMACEUTICALS INC ORIC | $12.7m1.19% | New |
| REVOLUTION MEDICINES INC RVMD | $12.0m1.12% | Added +75.0k |
| 89BIO INC ETNB | $10.3m0.96% | Unchanged |
| PENUMBRA INC PEN | $10.3m0.96% | Added +5.0k |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $9.4m0.88% | Unchanged |
| INSPIRE MED SYS INC INSP | $9.1m0.85% | Added +5.0k |
| ACADIA HEALTHCARE COMPANY IN ACHC | $9.1m0.85% | Added +150.0k |
| BEAM THERAPEUTICS INC BEAM | $8.5m0.79% | New |
| HOLOGIC INC HOLX | $8.1m0.76% | New |
| TARSUS PHARMACEUTICALS INC TARS | $8.1m0.76% | Unchanged |
| REZOLUTE INC RZLT | $8.0m0.75% | Added +1.3m |
| RHYTHM PHARMACEUTICALS INC RYTM | $7.6m0.71% | New |
| BAXTER INTL INC BAX | $7.6m0.71% | Reduced -250.0k |
| ABBVIE INC ABBV | $7.4m0.69% | Reduced -20.0k |
| MCKESSON CORP MCK | $7.3m0.68% | Reduced -2.0k |
| ROIVANT SCIENCES LTD ROIV | $6.8m0.63% | Unchanged |
| IRHYTHM TECHNOLOGIES INC IRTC | $6.2m0.58% | New |
| AGILENT TECHNOLOGIES INC A | $5.9m0.55% | New |
| REGENXBIO INC RGNX | $5.7m0.54% | Reduced -225.0k |
| VERONA PHARMA PLC VRNA | $5.7m0.53% | Reduced -55.0k |
| ALIGNMENT HEALTHCARE INC ALHC | $5.6m0.52% | Added +200.0k |
| ATYR PHARMA INC ATYR | $5.3m0.50% | Added +350.0k |
| EXACT SCIENCES CORP EXAS | $5.3m0.50% | New |
| WATERS CORP WAT | $5.2m0.49% | Reduced -5.0k |
| GLAUKOS CORP GKOS | $5.2m0.48% | New |
| ELANCO ANIMAL HEALTH INC ELAN | $5.0m0.47% | New |
| COOPER COS INC COO | $5.0m0.47% | New |
| CRISPR THERAPEUTICS AG CRSP | $4.9m0.45% | Reduced -50.0k |
| PROTARA THERAPEUTICS INC TARA | $4.2m0.40% | Unchanged |
| BIOHAVEN LTD BHVN | $4.2m0.40% | Added +125.0k |
| SANA BIOTECHNOLOGY INC SANA | $4.1m0.38% | Reduced -500.0k |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $3.6m0.34% | New |
| SCHOLAR ROCK HLDG CORP SRRK | $3.5m0.33% | Reduced -25.0k |
| NURIX THERAPEUTICS INC NRIX | $3.5m0.33% | Added +35.0k |
| JASPER THERAPEUTICS INC JSPR | $3.3m0.31% | Added +15.0k |
| CATALYST PHARMACEUTICALS INC CPRX | $3.3m0.30% | Unchanged |
| ALKERMES PLC ALKS | $2.9m0.27% | Reduced -50.0k |
| TERNS PHARMACEUTICALS INC COM | $2.6m0.24% | Unchanged |
| ARCUS BIOSCIENCES INC RCUS | $2.4m0.23% | New |
| OSCAR HEALTH INC OSCR | $2.1m0.20% | Reduced -100.0k |
| TENAX THERAPEUTICS INC TENX | $961.9k0.09% | Unchanged |
| ALTO NEUROSCIENCE INC ANRO | $880.0k0.08% | Unchanged |
Sold out since Q1 2025
| Security | Value then |
|---|---|
| GILEAD SCIENCES INC GILD | $19.6m175.0k shares |
| ASCENDIS PHARMA A/S | $15.6m100.0k shares |
| BLUEPRINT MEDICINES CORP BPMC | $12.8m145.0k shares |
| KRYSTAL BIOTECH INC KRYS | $10.8m60.0k shares |
| TEVA PHARMACEUTICAL INDS LTD | $7.7m500.0k shares |
| MASIMO CORP MASI | $7.5m45.0k shares |
| BRISTOL-MYERS SQUIBB CO BMY | $6.1m100.0k shares |
| IQVIA HLDGS INC IQV | $5.3m30.0k shares |
| PTC THERAPEUTICS INC PTCT | $5.1m100.0k shares |
| DYNE THERAPEUTICS INC DYN | $4.7m450.0k shares |
| LABCORP HOLDINGS INC LH | $4.7m20.0k shares |
| BECTON DICKINSON & CO BDX | $4.6m20.0k shares |
| CRINETICS PHARMACEUTICALS IN CRNX | $4.2m125.0k shares |
| GLOBUS MED INC GMED | $3.7m50.0k shares |
| BIONTECH SE BNTX | $3.6m40.0k shares |
| BRIDGEBIO PHARMA INC BBIO | $3.5m100.0k shares |
| THE CIGNA GROUP CI | $3.3m10.0k shares |
| VERASTEM INC VSTM | $3.0m500.0k shares |
| REPLIGEN CORP RGEN | $2.5m20.0k shares |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $2.2m175.0k shares |
| MEREO BIOPHARMA GROUP PLC MREO | $1.8m800.0k shares |
| CABALETTA BIO INC CABA | $1.2m850.0k shares |
| PALATIN TECHNOLOGIES INC | $582.9k1.0m shares |
| FATE THERAPEUTICS INC FATE | $553.1k700.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| CYTOKINETICS INC CYTK · Call | $16.5m500.0k shares | New |
| VIKING THERAPEUTICS INC VKTX · Call | $5.3m200.0k shares | Unchanged |